0 CHECKOUT

Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014

  • ID: 2773961
  • February 2014
  • Region: Global
  • 66 pages
  • GlobalData
1 of 3

Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014

Summary

Our clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Hairy Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hairy Cell Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hairy Cell Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Hairy Cell Leukemia
Symptoms of HCL are:
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Countries: Proportion of Hairy Cell Leukemia to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Hairy Cell Leukemia
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hairy Cell Leukemia Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Hairy Cell Leukemia
May 16, 2013: AstraZeneca's MedImmune Enrolls First Patient In Phase III Leukemia Trial Of Moxetumomab Pasudotox
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
TG Therapeutics, Inc.
Clinical Trial Overview of TG Therapeutics, Inc.
Jacobus Pharmaceutical Company
Clinical Trial Overview of Jacobus Pharmaceutical Company
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
Daiichi Sankyo Company, Limited
Clinical Trial Overview of Daiichi Sankyo Company, Limited
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
The University of Chicago
Clinical Trial Overview of The University of Chicago
Thomas Jefferson University
Clinical Trial Overview of Thomas Jefferson University
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Northwestern University
Clinical Trial Overview of Northwestern University
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Swiss Group for Clinical Cancer Research
Clinical Trial Overview of Swiss Group for Clinical Cancer Research
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2014-
Proportion of Hairy Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014-
Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014-
Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014-
Hairy Cell Leukemia Therapeutics, Global, Suspended Clinical Trials, 2014-
Hairy Cell Leukemia Therapeutics, Global, Terminated Clinical Trials, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Hairy Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TG Therapeutics, Inc., 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Group for Clinical Cancer Research, 2014-

List of Figures
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014-
Proportion of Hairy Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014-
Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014-
Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2014-
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014-
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Hairy Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014-
Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014-
GlobalData Methodology

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.